OxySure (OXYS) is Undervalued and Has Crossed Above Its SqueezeTrigger Price
OxySure (OXYS) is Undervalued and Has Crossed Above Its SqueezeTrigger Price.
FRISCO, TX— (Marketwired - November 26, 2014) – OxySure Systems, Inc. (OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology announced today that WEALTHMAKERS.COM, www.wealthmakers.com, a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a research report on OxySure Systems (OTCQB: OXYS). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.83, the Group Correlation and the projected short squeeze valuation of $4.04 per share.
Click here to download report:
OxySure Systems, Inc. (OTCQB: OXYS), a medical technology company, is engaged in the design, manufacture, and distribution of respiratory and emergency medical solutions. The Company manufactures the award winning OxySure Model 615, a portable emergency oxygen system for mass lay person use. Using the Company’s proprietary “oxygen from powder” technology, Model 615 is creating a new category in emergency oxygen availability for the public, and bridges the gap between the onset of any medical emergency and the time first responders arrive on the scene. The Company also offers complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. The company sells its products to institutional customers through distributors, sub-distributors, and sales agents in the United States and internationally. OxySure Systems, Inc. was founded in 2004 and is headquartered in Frisco, Texas.
WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), http://www.wopronline.com , a military-style computer that uses parallel processing, genetic algorithms, neural networks and unbridled computing power to analyze exactly what event (technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management's control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2013.
WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has been compensated in the amount of $1,116 per month for six months of data provided in this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures.
Stonegate Securities, Inc.
214-987-4121 / 972-294-6461
Renmark Financial Communications, Inc.
Tel.: (416) 644-2020 or (514) 939-3989